The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
Open accessAbstract
BACKGROUND: Inflammation has a critical role in the pathogenesis and progression of cancer. The lymphocyte to monocyte ratio (LMR) could be shown to be prognostic in haematologic neoplasia. In this study, we analysed the LMR with clinical outcome in stage II and III colon cancer patients. METHODS: Three hundred and seventy-two patients with stage II and III colon cancer were included in this retrospective study. Kaplan-Meier curves and multivariate Cox-regression analyses were calculated for time to recurrence (TTR) and overall survival (OS). RESULTS: Including all patients, the elevated preoperative LMR was significantly associated with increased TTR and OS in multivariate analysis (HR: 0.47, 95%CI: 0.29-0.76, P=0.002; HR: 0.51, 95%CI: 0.31-0.83, P=0.007; respectively). In subanalyses, the association was limited to patients with stage III (HR: 0.40, 95%CI: 0.22-0.72, P=0.002), in contrast to patients with stage II (HR: 0.40, 95%CI: 0.28-1.66, P=0.397). When the subgroup of patients with 'high-risk' LMR≤2.83 was analysed, no benefit of adjuvant 5-FU-based chemotherapy could be found (HR: 0.99; 95%CI: 0.60-1.63; P=0.953). CONCLUSION: The LMR might be an independent prognostic marker for TTR in stage III colon cancer patients. Our results further suggest that high-risk patients based on the LMR do not benefit from adjuvant chemotherapy. Independent validation of our findings is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging
O'Connell, J. B., Maggard, M. A., & Ko, C. Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh275 · Cited by 1,599
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Progress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Trophic macrophages in development and disease
Pollard, J. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2528 · Cited by 1,178
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Mlecnik, B., Tosolini, M., Kirilovsky, A., Berger, A., Bindea, G., Meatchi, T., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Pagès, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5425 · Cited by 1,009
Cancer classification using the Immunoscore: a worldwide task force
Galon, J., Pagès, F., Marincola, F. M., Angell, H. K., Thurin, M., Lugli, A., Zlobec, I., Berger, A., Bifulco, C., Botti, G., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-205 · Cited by 791
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., Westerga, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1077 · Cited by 537
Cho, H., Hur, H. W., Kim, S. W., Kim, S. H., Kim, J. H., Kim, Y. T., & Lee, K. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0516-3 · Cited by 529
Pathways connecting inflammation and cancer
Allavena, P., Garlanda, C., Borrello, M. G., Sica, A., & Mantovani, A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.003 · Cited by 437
Kwon, H.-C., Kim, S. H., Oh, S. Y., Lee, S., Lee, J. H., Choi, H.-J., Park, K.-J., Roh, M. S., Kim, S.-G., Kim, H.-J., et al. (2012) · Biomarkers · doi:10.3109/1354750x.2012.656705 · Cited by 409
Gomez, D., Farid, S., Malik, H. Z., Young, A. L., Toogood, G. J., Lodge, J. P. A., & Prasad, K. R. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9552-6 · Cited by 402
Hoffmann, T. K., Dworacki, G., Tsukihiro, T., Meidenbauer, N., Gooding, W. E., Johnson, J. T., & Whiteside, T. L. (2002) · PubMed · Cited by 388
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Swann, J. B., Vesely, M. D., Silva, A., Sharkey, J., Akira, S., Schreiber, R. D., & Smyth, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708594105 · Cited by 308
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
Raungkaewmanee, S., Tangjitgamol, S., Manusirivithaya, S., Srijaipracharoen, S., & Thavaramara, T. (2012) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2012.23.4.265 · Cited by 246
Absenger, G., Szkandera, J., Pichler, M., Stotz, M., Arminger, F., Weissmueller, M., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.346 · Cited by 225
Self-citationPeripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma
Porrata, L. F., Ristow, K., Colgan, J. P., Habermann, T. M., Witzig, T. E., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Nowakowski, G. S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.050138 · Cited by 208
Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
Sangaletti, S., Di Carlo, E., Gariboldi, S., Miotti, S., Cappetti, B., Parenza, M., Rumio, C., Brekken, R. A., Chiodoni, C., & Colombo, M. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1327 · Cited by 207
Fidler, I. J., & Schroit, A. J. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90009-1 · Cited by 188
RABINOWICH, H., Cohen, R., BRUDERMAN, I., Steiner, Z. P., & Klajman, A. (1987) · PubMed · Cited by 177
Li, Z., Huang, J.-J., Xia, Y., Sun, J., Huang, Y., Wang, Y., Zhu, Y.-J., Li, Y.-J., Zhao, W., Wei, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041658 · Cited by 148
Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells
Heuff, G., Oldenburg, H. S. A., Boutkan, H., Visser, J. J., Beelen, R. H. J., van Rooijen, N., Dijkstra, C. D., & Meyer, S. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01517045 · Cited by 108
Mroczko, B., Groblewska, M., Wereszczyńska-Siemiątkowska, U., Okulczyk, B., Kędra, B., Łaszewicz, W., Dâbrowski, A., & Szmitkowski, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.02.037 · Cited by 108
Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow
Evani, S. J., Prabhu, R. G., Gnanaruban, V., Finol, E. A., & Ramasubramanian, A. K. (2013) · The FASEB Journal · doi:10.1096/fj.12-224824 · Cited by 101
Kaneko, M., Nozawa, H., Sasaki, K., Hongo, K., Hiyoshi, M., Tada, N., Murono, K., Nirei, T., Kawai, K., Sunami, E., et al. (2012) · Oncology · doi:10.1159/000337228 · Cited by 81
Zikos, T. A., Donnenberg, A. D., Landreneau, R. J., Luketich, J. D., & Donnenberg, V. S. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0996-4 · Cited by 81
Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma
Idowu, O. K., Ding, Q., Taktak, A. F. G., Chandrasekar, C. R., & Yin, Q. (2012) · Biomarkers · doi:10.3109/1354750x.2012.699554 · Cited by 69
Porrata, L. F., Ristow, K. M., Habermann, T. M., Witzig, T. E., Colgan, J. P., Inwards, D. J., Ansell, S. M., Micallef, I. N., Johnston, P. B., Nowakowski, G. S., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09067.x · Cited by 67
Batty, N., Ghonimi, E., Feng, L., Fayad, L., Younes, A., Rodriguez, M. A., Romaguera, J. E., McLaughlin, P. J., Samaniego, F., Kwak, L. W., et al. (2012) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2012.09.009 · Cited by 38
Cited by
Monocyte heterogeneity and functions in cancer
Olingy, C. E., Dinh, H. Q., & Hedrick, C. C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0818-311r · Cited by 579
Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients
Yamamoto, T., Kawada, K., & Obama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158002 · Cited by 445
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Chang, Y., Jeong, S. W., Young Jang, J., & Jae Kim, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218165 · Cited by 336
Nishijima, T. F., Muss, H. B., Shachar, S. S., Tamura, K., & Takamatsu, Y. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.10.003 · Cited by 324
Ying, H.-Q., Deng, Q.-W., He, B.-S., Pan, Y.-Q., Wang, F., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2014) · Medical Oncology · doi:10.1007/s12032-014-0305-0 · Cited by 317
Metadata
- Authors
- Stotz, M., Pichler, M., Absenger, G., Szkandera, J., Arminger, F., Schaberl-Moser, R., Samonigg, H., Stojakovic, T., & Gerger, A.
- Venue
- British Journal of Cancer
- Published
- 2013-12-19
- Volume
- 110
- Issue
- 2
- Pages
- 435-440
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2084222857
- Cited by
- 310
- References
- 38
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.